CD163 and graft versus host disease: Using machine learning models to predict the potential mechanisms and targets of CD163, MCEMP1, and RETN proteins, CD163, MCEMP1 and RETN may jointly regulate complement and coagulation cascades, toll like receptor signaling pathway, graft versus host disease, type I diabetes mellitus.